1. Academic Validation
  2. Solid-state studies of the triclinic (Z' = 2) antiprotozoal drug ternidazole

Solid-state studies of the triclinic (Z' = 2) antiprotozoal drug ternidazole

  • J Pharm Sci. 2011 Jun;100(6):2258-66. doi: 10.1002/jps.22460.
Nathalie Mahé 1 Marc-Antoine Perrin Maria Barrio Béatrice Nicolaï Ivo B Rietveld Josep-Lluís Tamarit René Céolin
Affiliations

Affiliation

  • 1 Laboratoire de Chimie Physique (former EA4066), Faculté de Pharmacie, Université Paris Descartes, 75006 Paris, France.
Abstract

The solid-state properties of antiprotozoal ternidazole (3-(2-methyl-5-nitroimidazol-1-yl)-propan-1-ol) have been studied. Crystals are triclinic in the temperature interval between 100 and 333 K (melting point) with two different molecular conformations present in the asymmetric unit (Z' = 2) and two of each conformer make up a tetramer held together by hydrogen bonding. Its melting enthalpy at 333 K is 25.65 (± 1.29) kJ · mol(-1). Linear plots were obtained for the melting temperature versus pressure (dP/dT = 5.67 (± 0.08) MPa · K(-1)] and the glass transition versus pressure [dP/dT = 7.73 (±1.76) MPa · K(-1)]. No crystalline polymorphism could be detected; thus, the single-crystal structure that has been found is most likely the stable one.

Figures
Products